Slayback Pharma Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SLAYBACK PHARMA LLC, and what generic alternatives to SLAYBACK PHARMA LLC drugs are available?
SLAYBACK PHARMA LLC has thirteen approved drugs.
There are three US patents protecting SLAYBACK PHARMA LLC drugs.
Summary for Slayback Pharma Llc
US Patents: | 3 |
Tradenames: | 13 |
Ingredients: | 13 |
NDAs: | 13 |
PTAB Cases with Slayback Pharma Llc as petitioner: | See PTAB cases with Slayback Pharma Llc as petitioner |
Drugs and US Patents for Slayback Pharma Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Slayback Pharma Llc | METHYLPREDNISOLONE ACETATE | methylprednisolone acetate | INJECTABLE;INJECTION | 214870-002 | May 10, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slayback Pharma Llc | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 212791-002 | Dec 4, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Slayback Pharma Llc | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 212791-003 | May 8, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Slayback Pharma Llc | TESTOSTERONE CYPIONATE | testosterone cypionate | SOLUTION;INTRAMUSCULAR | 216318-001 | Jun 2, 2022 | DISCN | Yes | No | 11,311,554 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Slayback Pharma Llc | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 211501-001 | Sep 1, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.